MedPath

Role of Brihat Varunadi Kwath with Shveta Parpati in renal calculus.

Phase 1/2
Not yet recruiting
Conditions
Calculus of urinary tract in diseases classified elsewhere,
Registration Number
CTRI/2020/08/027073
Lead Sponsor
SULJEET BARANDA
Brief Summary

this is a random parallel group trial of patient suffering from calculus of urinary tract. in one group patient will be given 20 ml. brihat varunadi kwatha and mix with 250 mg. shveta parpati twice in a day. in other group patient will be given by doctors prescription in hospital opd/ipd of DSRRAU jodhpur. and compare the result of both groups.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Clinically and pathologically diagnosed patients of all types of Mootrashmaris.Size of calculus should not be less than 10 mm.

Exclusion Criteria

Patients of Benign Prostatic Hyperplasia,Renal failure, renal tuberculosis, diabetes mellitus, Multiple urinary stones and suffering from any other systemic disorder.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in subjective and objective parameterFollow up at 15 day Interval
Secondary Outcome Measures
NameTimeMethod
To find out the efficacy of treatment1 month

Trial Locations

Locations (1)

Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University, University Hospital of Ayurveda Jodhpur

🇮🇳

Jodhpur, RAJASTHAN, India

Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University, University Hospital of Ayurveda Jodhpur
🇮🇳Jodhpur, RAJASTHAN, India
Dr Rakesh Kumar Sharma
Principal investigator
9166216760
rksharma_jumbo@yahoo.co.in

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.